The Irish clinical trials group Icon has made its second acquisition in the space of a week, and is paying $5.8 million (€5.9 million) for YRCR, a British pharmaceutical regulatory affairs consulting group. Based in Henley in the UK, YRCR provides advice and support, including marketing authorisation applications for European, American and Japanese clients.
Icon buys second firm this week
The Irish clinical trials group Icon has made its second acquisition in the space of a week, and is paying $5
From maternity leave to remote working: Submit your work-related questions here
Listen to Inside Business podcast for a look at business and economics from an Irish perspective
Sign up to the Business Today newsletter for the latest new and commentary in your inbox
Trump responds to US midterms defeat as Democrats win full control of the Texas House
Scarlett Faulkner ‘terrified’ of what boyfriend’s ex-wife would do, trial hears
Ireland’s Population Crash on RTÉ One: Miriam O’Callaghan is compelling at the heart of this doc
Fine Gael motion to distinguish party from ‘woke left’ rejected for ardfheis
Judge ponders whether head of Christian Brothers would have to obey Pope in abuse case
Business Today
Get the latest business news and commentary from our expert business team in your inbox every weekday morning